Nostrum exempla monstrabit ad cancer treatment-related morbo focus in autoimmune complications, quae potest oriri durante cancer therapies. Hae exempla auxilium in studeo interactiones inter cancer treatments et immune ratio, adiuvat in progressionem consilia ad mitigare adversa autoimmune respondeo in cancer aegris.